Cannabis Suisse Valuation
| CSUI Stock | USD 0.01 0.01 62.88% |
Cannabis Suisse seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cannabis Suisse Corp from analyzing the firm fundamentals such as Current Valuation of 3.37 M, return on asset of -3.08, and Shares Owned By Insiders of 30.50 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cannabis Suisse's price fluctuation is out of control at this time. Calculation of the real value of Cannabis Suisse Corp is based on 3 months time horizon. Increasing Cannabis Suisse's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cannabis Suisse is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cannabis Pink Sheet. However, Cannabis Suisse's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0085 | Real 0.00816 | Hype 0.01 | Naive 0.005613 |
The intrinsic value of Cannabis Suisse's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Cannabis Suisse's stock price.
Estimating the potential upside or downside of Cannabis Suisse Corp helps investors to forecast how Cannabis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cannabis Suisse more accurately as focusing exclusively on Cannabis Suisse's fundamentals will not take into account other important factors: Cannabis Suisse Total Value Analysis
Cannabis Suisse Corp is currently anticipated to have valuation of 3.37 M with market capitalization of 1.34 M, debt of 102.73 K, and cash on hands of 5. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cannabis Suisse fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.37 M | 1.34 M | 102.73 K | 5 |
Cannabis Suisse Investor Information
About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Cannabis Suisse Corp had not issued any dividends in recent years. The entity had 20:1 split on the 28th of February 2019. Based on the measurements of operating efficiency obtained from Cannabis Suisse's historical financial statements, Cannabis Suisse Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Cannabis Suisse Asset Utilization
One of the ways to look at asset utilization of Cannabis is to check how much profit was generated for every dollar of assets it reports. Cannabis Suisse Corp shows a negative utilization of assets of -3.08 percent, losing $0.0308 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cannabis Suisse Corp shows how discouraging it operates for each dollar spent on its assets.Cannabis Suisse Ownership Allocation
Cannabis Suisse holds a total of 40.65 Million outstanding shares. Cannabis Suisse Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cannabis Suisse Profitability Analysis
The company reported the previous year's revenue of 7.77 K. Net Loss for the year was (187.89 K) with profit before overhead, payroll, taxes, and interest of 6.04 K.About Cannabis Suisse Valuation
An absolute valuation paradigm, as applied to Cannabis Pink Sheet, attempts to find the value of Cannabis Suisse Corp based on its fundamental and basic technical indicators. By analyzing Cannabis Suisse's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cannabis Suisse's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cannabis Suisse. We calculate exposure to Cannabis Suisse's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cannabis Suisse's related companies.Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California. CANNABIS SUISSE is traded on OTC Exchange in the United States.
8 Steps to conduct Cannabis Suisse's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cannabis Suisse's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cannabis Suisse's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cannabis Suisse's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cannabis Suisse's revenue streams: Identify Cannabis Suisse's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cannabis Suisse's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cannabis Suisse's growth potential: Evaluate Cannabis Suisse's management, business model, and growth potential.
- Determine Cannabis Suisse's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cannabis Suisse's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cannabis Suisse Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 33.1 M | |
| Retained Earnings | -1.1 M |
Complementary Tools for Cannabis Pink Sheet analysis
When running Cannabis Suisse's price analysis, check to measure Cannabis Suisse's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Suisse is operating at the current time. Most of Cannabis Suisse's value examination focuses on studying past and present price action to predict the probability of Cannabis Suisse's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Suisse's price. Additionally, you may evaluate how the addition of Cannabis Suisse to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |